The new iLet Bionic Pancreas system was cleared by the FDA for patients 6 and older with type 1 diabetes, the agency announced Friday. The pocket-sized system features the the Beta Bionics iLet ACE ...

The US Food and Drug Administration (FDA) has cleared Beta Bionics's iLet ACE Pump and the iLet Dosing Decision Software for people ages 6 years and older with type 1 diabetes. Working together with a ...

The Enquirer is investigating readers’ medical bills. For our first story, we talked to Ashley Hack, the mom of a 12-year-old with Type 1 diabetes. Do you have a bill you want us to check out? Email ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the iLet ACE insulin pump and iLet dosing decision software for people with type 1 diabetes. The ...

San Antonio physicians have begun prescribing an artificial intelligence-enabled device that regulates blood sugar levels to young people with Type 1 diabetes. Dr. Jane Lynch, professor of pediatric ...

The investigational insulin-only iLet Bionic Pancreas (Beta Bionics) reduced A1c without increasing hypoglycemia in adults and children with type 1 diabetes with greater automation than currently ...

Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A fully ...

Credit: Shutterstock. The iLet Bionic Pancreas uses an adaptive closed-loop algorithm requiring only a user’s body weight for start-up and no additional insulin dosing parameters. The Food and Drug ...